MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Akorn Company Profile (NASDAQ:AKRX)

Consensus Ratings for Akorn (NASDAQ:AKRX) (?)
Ratings Breakdown: 4 Hold Rating(s), 8 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $34.36 (23.73% upside)

Analysts' Ratings History for Akorn (NASDAQ:AKRX)
Show:
DateFirmActionRatingPrice TargetActions
5/26/2016Leerink SwannReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/17/2016GuggenheimReiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/17/2016RBC CapitalReiterated RatingOutperform$37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2016Jefferies GroupReiterated RatingBuy$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/22/2016Craig HallumReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2016Piper JaffrayReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2016SusquehannaLower Price TargetNeutral$32.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2016William BlairReiterated RatingOutperform$58.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/22/2016S&P Equity ResearchLower Price Target$25.98 -> $21.97View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/21/2016Raymond JamesLower Price Target$53.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/21/2016NomuraLower Price TargetBuy$46.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2016Deutsche BankLower Price TargetBuy$40.00 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/14/2016JPMorgan Chase & Co.Lower Price TargetOverweight$50.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/9/2015JMP SecuritiesInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/27/2015Avondale PartnersInitiated CoverageOutperform$56.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2015Needham & Company LLCDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2015WallachBeth CapitalBoost Price TargetBuy$43.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2015Sterne Agee CRTInitiated CoverageBuy$52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/13/2014CRT CapitalUpgradeFair Value -> Buy$46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/26/2014 forward)
Earnings History for Akorn (NASDAQ:AKRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
5/16/2016        
5/16/2016Q116$0.43$0.54$268.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015Q414$0.45$0.50$218.87 million$227.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2014Q314$0.25$0.27$155.20 million$132.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2014Q214$0.20$0.25$145.16 million$150.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2014Q114$0.15$0.16$91.44 million$90.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2014Q413$0.14$0.14$83.37 million$85.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2013Q313$0.14$0.15$80.43 million$81.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2013Q2 2013$0.13$0.14$75.06 million$77.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2013Q1 2013$0.14$0.13$74.07 million$73.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2013Q4 2012$0.12$0.13$69.42 million$71.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2012Q312$0.13$0.12$69.59 million$69.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2012$0.12$0.12ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2012$0.12$0.13ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/6/2012$0.09$0.11ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2011$0.06$0.13ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Akorn (NASDAQ:AKRX)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.50$0.50$0.50
Q2 20162$0.47$0.53$0.50
Q3 20161$0.53$0.53$0.53
Q4 20161$0.52$0.52$0.52
(Data provided by Zacks Investment Research)
Dividend History for Akorn (NASDAQ:AKRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Akorn (NASDAQ:AKRX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/14/2016Joseph BonaccorsiSVPSell6,500$29.84$193,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2016Kenneth AbramowitzDirectorSell14,675$30.16$442,598.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2016Bruce KutinskyCOOSell142,000$31.12$4,419,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2016Ronald M JohnsonDirectorSell7,542$31.49$237,497.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2016Kenneth AbramowitzDirectorSell10,900$31.37$341,933.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2016Joseph BonaccorsiSVPSell90,250$31.23$2,818,507.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2016Alan D WeinsteinDirectorSell50,000$30.93$1,546,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/21/2015Mark M SilverbergVPSell29,000$55.00$1,595,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2015John N KapoorDirectorBuy19,000$44.26$840,940.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2015Rajat RaiCEOBuy5,000$47.70$238,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2015Joseph BonaccorsiInsiderSell40,827$47.33$1,932,341.91View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2015Ronald M JohnsonDirectorSell17,173$46.44$797,514.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/26/2015Rajat RaiCEOSell873,985$41.89$36,611,231.65View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2015Mark M SilverbergVPSell38,602$41.00$1,582,682.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2015Ronald M JohnsonDirectorSell17,173$40.46$694,819.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Ronald M JohnsonDirectorSell14,300$36.12$516,516.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Timothy A DickCFOSell30,150$36.03$1,086,304.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Brian TambiDirectorSell1,200$41.86$50,232.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2014Adrienne L GravesDirectorSell9,557$41.09$392,697.13View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2014John N KapoorDirectorSell50,000$41.19$2,059,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2014John R SabatVPSell43,173$40.53$1,749,801.69View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Timothy A DickCFOSell30,875$39.23$1,211,226.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Timothy A DickCFOSell122,222$44.08$5,387,545.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Timothy A DickCFOSell122,222$35.24$4,307,103.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2014Brian TambiDirectorSell13,800$38.00$524,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2014Joseph BonaccorsiInsiderSell116,800$37.89$4,425,552.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2014Kenneth AbramowitzDirectorSell4,500$36.54$164,430.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2014Rajat RaiCEOSell147,000$36.78$5,406,660.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2014Timothy A DickCFOSell45,000$37.61$1,692,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2014Alan D WeinsteinDirectorSell5,000$38.49$192,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2014John N KapoorDirectorSell50,000$38.99$1,949,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014Rajat RaiCEOSell903,659$33.62$30,381,015.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/13/2014Brian TambiDirectorBuy1,000$27.62$27,620.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2014Rajat RaiCEOBuy5,000$26.76$133,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2014Kenneth AbramowitzDirectorSell2,557$26.79$68,502.03View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2013Alan WeinsteinDirectorSell20,000$25.52$510,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2013Kenneth AbramowitzDirectorSell5,000$25.35$126,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2012Alan D WeinsteinDirectorBuy30,500$13.67$416,935.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Akorn (NASDAQ:AKRX)
DateHeadline
06/25/16 02:25 PMStock Tracing Lower on the Week Akorn, Inc. (NASDAQ:AKRX) - Engelwood Daily
06/25/16 02:25 PMAkorn Incorporated (NASDAQ:AKRX) Sellers Covered 10.4% of Their Shorts - Press Telegraph
06/25/16 02:25 PMArdsley Advisory Partners Increased Akorn INC (NASDAQ:AKRX) by $33.10 Million as Shares Declined - Press Telegraph
06/24/16 02:25 PMAkorn (AKRX) Trading Near $28.61 Support Level
06/20/16 02:24 PMAnalyst Views For The Week Ahead: Akorn, Inc. (NASDAQ:AKRX) - Fiscal Standard
06/16/16 02:25 PMPrice Review of Stocks: Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) , Akorn, Inc. (NASDAQ:AKRX) - Street Updates
06/16/16 02:25 PMEarnings in Focus: Akorn, Inc. (NASDAQ:AKRX), Westlake Chemical Corp. (NYSE:WLK) - Beacon Chronicle
06/15/16 02:27 PMEarnings Report of the Stocks: Akorn, Inc. (NASDAQ:AKRX), Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) - Beacon Chronicle
06/15/16 07:14 AMAkorn (AKRX) Shares Cross Below 200 DMA - Nasdaq
06/13/16 02:25 PMRecent Movements of Stocks: Akorn, Inc. (NASDAQ:AKRX) , CTI BioPharma Corp. (NASDAQ:CTIC) - Street Updates
06/12/16 07:44 PMTechnical Analysis on Drugs - Generic Equities -- Akorn, Ironwood Pharma, Catalyst Pharma, and Pacira Pharma
06/11/16 10:37 AMTake a look at Analyst Tips: Akorn, Inc. (NASDAQ:AKRX) , Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) - Street Updates
06/09/16 11:16 AMRecent Trading Alert: Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) , Akorn, Inc. (NASDAQ:AKRX) - Street Updates
06/08/16 10:52 AMMost recent Trading report: Thermo Fisher Scientific Inc (NYSE:TMO) , Akorn, Inc. (NASDAQ:AKRX) - Street Updates
06/07/16 02:26 PMEarnings Report of the Stocks: Akorn, Inc. (NASDAQ:AKRX), Darling Ingredients Inc. (NYSE:DAR) - Beacon Chronicle
06/07/16 12:04 PMAKORN INC Financials -
06/06/16 02:26 PMComprehensive Analysis of: Akorn, Inc. (NASDAQ:AKRX), Terex Corporation (NYSE:TEX) - Beacon Chronicle
06/03/16 02:25 PMHealthcare Moving Stocks: Boston Scientific Corporation (NYSE:BSX) , Akorn, Inc. (NASDAQ:AKRX) - Is stories
06/03/16 02:25 PMComprehensive Report on: Akorn, Inc. (NASDAQ:AKRX), Nucor Corporation (NYSE:NUE) - Beacon Chronicle
06/02/16 08:23 PMThe Insider Activity Don't Lie: Akorn, Inc. (NASDAQ:AKRX) - iStreetWire - iStreetWireThe Insider Activity Don't Lie: Akorn, Inc. (NASDAQ:AKRX)iStreetWireAkorn, Inc. (AKRX) down -0.03 per cent in the past week, is under coverage of 15 analysts who collectively recommend a hold rating on stock. 11 of the analysts have a buy or better rating; the 0 sells versus 0 underperforms. The 13 equity analysts who ...and more »
06/02/16 08:23 PMAkorn, Inc. (NASDAQ:AKRX): Rundown on Share Performance - HNN - Akorn, Inc. (NASDAQ:AKRX): Rundown on Share PerformanceHNNIn the latest trading period, Akorn, Inc. (NASDAQ:AKRX) shares have seen a change of +0.10%. During the period, the stock has moved up to a high of $31.48 and dipped to a low of $30.65. Looking at a broader view of stock performance, shares have range ...and more »
06/02/16 08:23 PMPortfolio Of Healthcare Movers: Merck & Company, Inc. (NYSE:MRK) , Akorn, Inc. (NASDAQ:AKRX) - Is stories - Is storiesPortfolio Of Healthcare Movers: Merck & Company, Inc. (NYSE:MRK) , Akorn, Inc. (NASDAQ:AKRX)Is storiesMerck & Company, Inc. (NYSE:MRK) increased +0.12% to $56.33 while traded 6.69 million shares on 6/1/2016. The stock price negotiated for value between $55.95 to $56.52 in recent trading session. During the past 52 weeks, the stock's price witnessed a ...and more »
06/02/16 11:03 AMWill You Buy These Stocks? - Akorn, Inc. (NASDAQ:AKRX), Cameco Corporation (NYSE:CCJ) - Beacon Chronicle - Beacon ChronicleWill You Buy These Stocks? - Akorn, Inc. (NASDAQ:AKRX), Cameco Corporation (NYSE:CCJ)Beacon ChronicleLast Trade: The Company closed its last session at $30.95 with the gain of 3.55%. The market capitalization of the company is $3.65 Billion, with the average Volume of 2.22 Million. The stock currently has its 52-Week High range of $48.53 and 52-week ...and more »
06/02/16 06:23 AMAKORN INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -
06/02/16 05:45 AMAkorn Updates Form S-8 Status by Filing Form 10-Q’s for First, Second and Third Quarters of 2015 - [at noodls] - LAKE FOREST, Ill., June 02, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that it has filed quarterly reports on Forms 10-Q with ...
06/01/16 02:27 PMNotable Earnings Analysis: Bristow Group, Inc. (NYSE:BRS), Akorn, Inc. (NASDAQ:AKRX) - Beacon Chronicle - Beacon ChronicleNotable Earnings Analysis: Bristow Group, Inc. (NYSE:BRS), Akorn, Inc. (NASDAQ:AKRX)Beacon ChronicleLast Trade: The Company closed its last session at $13.41 with the gain of 3.63%. The market capitalization of the company is $468.51 Million, with the average Volume of 802.96K. The stock currently has its 52-Week High range of $60.84 and 52-week low ...and more »
06/01/16 10:46 AMStock Review and Earnings Check on Akorn, Inc. (NASDAQ:AKRX) - HNN - Stock Review and Earnings Check on Akorn, Inc. (NASDAQ:AKRX)HNNInvestors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Akorn, Inc. (NASDAQ:AKRX) to ...and more »
05/31/16 02:26 PMTake a look at Analysts Tips: Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) , Akorn, Inc. (NASDAQ:AKRX) - Street Updates - Take a look at Analysts Tips: Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) , Akorn, Inc. (NASDAQ:AKRX)Street UpdatesIn the liquidity ratio analysis; Rock Creek Pharmaceuticals, Inc.'s (RCPI) The company has the institutional ownership of 10.50%. The stock's RSI amounts to 20.52. Akorn, Inc. (NASDAQ:AKRX) after beginning at $29.80, closed at $30.16 by building up ...and more »
05/31/16 02:26 PMAkorn, Inc. (NASDAQ:AKRX): Review of Stock Performance - HNN - Akorn, Inc. (NASDAQ:AKRX): Review of Stock PerformanceHNNDuring the most recent trading session, shares of Akorn, Inc. (NASDAQ:AKRX) have moved -0.33%. During the period, shares have moved to a high of $30.69 and fell to a low of $29.72. Broadening the view, the stock has range traded from $17.57 – 48.53 in ...and more »
05/31/16 02:26 PMSarepta Therapeutics (NASDAQ:SRPT) & Akorn, Inc. (NASDAQ:AKRX) Stocks in the News - Wall Street 24 - Sarepta Therapeutics (NASDAQ:SRPT) & Akorn, Inc. (NASDAQ:AKRX) Stocks in the NewsWall Street 24On Friday, Shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) lost -4.55% to $21.19. The share price is trading in a range of $20.82 – $23.04. The stock exchanged hands with 6.60 Million shares contrast to its average daily volume of 10.71 Million shares.and more »
05/31/16 08:24 AMStock Paining Investors: Akorn, Inc. (NASDAQ:AKRX) - HNN - Stock Paining Investors: Akorn, Inc. (NASDAQ:AKRX)HNNAkorn, Inc. (NASDAQ:AKRX)'s P/E is 24.03. P/E ratio indicates that a stock's price might be too high or too low when compared to its earnings. There are some investors who might think that a company with a high P/E is overpriced, though sometimes when ...and more »
05/31/16 07:42 AMAkorn to Present at Two Upcoming Investor Conferences - [at noodls] - LAKE FOREST, Ill., May 31, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that management will be presenting at the Jefferies 2016 ...
05/30/16 09:37 AMStock Rating Review for Akorn, Inc. (NASDAQ:AKRX) - HNN - Stock Rating Review for Akorn, Inc. (NASDAQ:AKRX)HNNCovering equity analysts presently have a consensus stock rating of 1.67 on shares of Akorn, Inc. (NASDAQ:AKRX). Covering analysts will often provide Sell, Hold, or Buy recommendations based on their advanced research. This consensus rating is ...and more »
05/29/16 06:00 PMAkorn, Inc. (NASDAQ:AKRX) Impact Score At 85 - RealistInvestor.com - Akorn, Inc. (NASDAQ:AKRX) Impact Score At 85RealistInvestor.comAlpha One explored various online articles released on Akorn, Inc. (NASDAQ:AKRX), and it set a daily sentiment score of 0.31 on the company. The entity has an algorithm in place to know stock sentiment on the share after exploring the content issued on ...and more »
05/28/16 11:13 PMAkorn (AKRX) Showing Bullish Technicals With Support At $28.74 - Akorn Inc. (AKRX) closed Thursday at $29.75 and technical indicators recently have been bullish. With those figures in place, the algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have identified a couple of attractive trading ...
05/27/16 09:27 AMStocks Analysts Ranking Summary: Boston Scientific Corporation (NYSE:BSX) , Akorn, Inc. (NASDAQ:AKRX) - Street Updates - Stocks Analysts Ranking Summary: Boston Scientific Corporation (NYSE:BSX) , Akorn, Inc. (NASDAQ:AKRX)Street UpdatesAkorn, Inc. (NASDAQ:AKRX) showed bearish move with loss of -2.14% after exchanging volume of 2.74 million shares in last trading session ended on 5/26/2016. The company recent traded volume was higher than its average volume of 2.22 million shares.and more »
05/26/16 09:40 AMTwin Securities INC Increased Akorn INC (NASDAQ:AKRX) by $48.70 Million as Shares Declined - CCH Daily News - Twin Securities INC Increased Akorn INC (NASDAQ:AKRX) by $48.70 Million as Shares DeclinedCCH Daily NewsTwin Securities Inc increased its stake in Akorn Inc (NASDAQ:AKRX) by 1568.49% based on its latest 2016Q1 regulatory filing with the SEC. Twin Securities Inc bought 2.12M shares as the company's stock declined 38.24% while stock markets rallied.Akorn, Inc. (NASDAQ:AKRX) Analyst Research Summary:ZergwatchBroker Roundup For Akorn, Inc. (NASDAQ:AKRX)Share Trading NewsAkorn, Inc. (NASDAQ:AKRX) One-Year Price Target At $38.77Investor Newswireall 4 news articles »
05/26/16 09:40 AMHealthcare Stocks Update: Pfizer, Inc. (NYSE:PFE) , Akorn, Inc. (NASDAQ:AKRX) - Is stories - Is storiesHealthcare Stocks Update: Pfizer, Inc. (NYSE:PFE) , Akorn, Inc. (NASDAQ:AKRX)Is storiesPfizer, Inc. (NYSE:PFE) increased +0.73% to $34.35 while traded 21.04 million shares on 5/25/2016. The stock price negotiated for value between $34.07 to $34.40 in recent trading session. During the past 52 weeks, the stock's price witnessed a minimum ...and more »
05/25/16 06:05 PMSachem Head Capital Management LP Decreased Stake in Akorn INC (NASDAQ:AKRX) by $19.32 Million as Shares ... - CCH Daily News - Sachem Head Capital Management LP Decreased Stake in Akorn INC (NASDAQ:AKRX) by $19.32 Million as Shares ...CCH Daily NewsScott Ferguson decreased its stake in Akorn Inc (NASDAQ:AKRX) by 19.31% based on its latest 2016Q1 regulatory filing with the SEC. Sachem Head Capital Management Lp sold 840,000 shares as the company's stock declined 38.24% while stock markets ...and more »
05/25/16 09:33 AMEarnings Review and Stock Rundown for Akorn, Inc. (NASDAQ:AKRX) - Wall Street Hints and News - Earnings Review and Stock Rundown for Akorn, Inc. (NASDAQ:AKRX)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Akorn, Inc. (NASDAQ:AKRX) to post ...and more »
05/25/16 09:33 AMAkorn, Inc. (NASDAQ:AKRX) One-Year Price Target At $38.77 - Investor Newswire - Akorn, Inc. (NASDAQ:AKRX) One-Year Price Target At $38.77Investor NewswireFirst Call has set a 52-week price target of $38.77 on Akorn, Inc. (NASDAQ:AKRX) stock after completion of its survey. For the approaching quarter, EPS estimate is set at $0.53 and for underway fiscal at $2.15. This estimate for next year is $2.40 ...and more »
05/24/16 11:22 PMAkorn, Inc. (NASDAQ:AKRX): Share Performance Update - Wall Street Hints and News - Akorn, Inc. (NASDAQ:AKRX): Share Performance UpdateWall Street Hints and NewsIn the latest session, shares of Akorn, Inc. (NASDAQ:AKRX) saw a move of +1.12%. During the session, the stock touched a high of $30.92 and saw a low of $30.47. Shares of the company have been recently recorded +8.61% away from the 200 day moving ...and more »
05/23/16 06:10 PMStock Rating Review for Akorn, Inc. (NASDAQ:AKRX) - Wall Street Hints and News - Stock Rating Review for Akorn, Inc. (NASDAQ:AKRX)Wall Street Hints and NewsCovering equity analysts presently have a consensus stock rating of 1.67 on shares of Akorn, Inc. (NASDAQ:AKRX). Covering analysts will often provide Sell, Hold, or Buy recommendations based on their advanced research. This consensus rating is ...and more »
05/23/16 06:10 PMAkorn, Inc. (NASDAQ:AKRX) Slapped with $36.6 Target Price - Wall Street Hints and News - Akorn, Inc. (NASDAQ:AKRX) Slapped with $36.6 Target PriceWall Street Hints and NewsThe sell-side consensus on the Street is anticipating that shares of Akorn, Inc. (NASDAQ:AKRX) reach $36.6. This is the mean estimate compiled by weighing in the analyst targets tracked by Zack's research. The top estimate is as high as $N/A near term ...and more »
05/22/16 05:37 PMAkorn, Inc. (NASDAQ:AKRX) One-Year Price Projection At $36.6 - RealistInvestor.com - Akorn, Inc. (NASDAQ:AKRX) One-Year Price Projection At $36.6RealistInvestor.comSell-side analysts are certain on the prospect of Akorn, Inc. (NASDAQ:AKRX) stock. As of 2016-05-21, the stock ABR stands at 1.67. This type of rating states that whenever a stock has a score of 5, investors should avoid investing in such stocks ...and more »
05/22/16 05:37 PMAlpha One Assigns Impact Score Of 87 To Akorn, Inc. (NASDAQ:AKRX) - Investor Newswire - Alpha One Assigns Impact Score Of 87 To Akorn, Inc. (NASDAQ:AKRX)Investor NewswireAlpha One analyzed the various web articles published on Akorn, Inc. (NASDAQ:AKRX), and thereafter it gave company a daily sentiment score of 0.155. The entity designs algorithm based assessment to known stock sentiment on stock after considering the ...Performance at a Glance on Akorn, Inc. (NASDAQ:AKRX)Wall Street Hints and NewsIs Buying Stock Like Akorn, Inc. Good Idea After Today's Bullish Options Activity?The Postall 4 news articles »
05/20/16 06:06 PMTraders Observing Biotech Stocks: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) , Akorn, Inc. (NASDAQ:AKRX) - Is stories - Is storiesTraders Observing Biotech Stocks: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) , Akorn, Inc. (NASDAQ:AKRX)Is storiesTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) began the transactions at $3.63 and seen negative move of -14.83% while the stock last trade documented at $2.47. On the other hand, its previous finishing price was noted at $2.90. The stock traded ...and more »
05/20/16 03:51 PMAKORN INC Files SEC form 8-K, Regulation FD Disclosure -
05/20/16 09:51 AMTrending Healthcare Stock Performance Update: Akorn (AKRX) - News Oracle - Trending Healthcare Stock Performance Update: Akorn (AKRX)News OracleBy looking at Akorn, Inc. (NASDAQ:AKRX) YTD (year to date) performance, the stock shows Negative value of -20.56%. If the YTD value is Negative, it means that the stock is trading poorly. If the YTD value is Positive, this means the stock is appreciating.and more »
05/20/16 09:19 AMBillionaire John Paulson Boosts Stakes in Endo Pharmaceuticals, Akorn; Plus Top Three New Positions -
About Akorn

Akorn logoAkorn Inc. (Akorn), together with its wholly owned subsidiaries, is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as animal and over-the-counter (OTC) consumer health products. The Company specializes in sterile and non-sterile dosage forms, including ophthalmics, injectables, oral liquids, otics, topicals, inhalants and nasal sprays. The Company operates in two segments: Prescription Pharmaceuticals, which is engaged in the sale of branded and generic prescription pharmaceuticals, and Consumer Health, which is engaged in the sale of branded and private label consumer and animal health products. The Company operates pharmaceutical manufacturing facilities in Decatur, Illinois; Somerset, New Jersey; Amityville, New York, and Paonta Sahib, Himachal Pradesh, India, as well as a central distribution warehouse in Gurnee, Illinois, and an additional warehousing facility in Amityville, New York.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drugs - Generic
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: AKRX
  • CUSIP: 00972810
Key Metrics:
  • Previous Close: $29.10
  • 50 Day Moving Average: $29.20
  • 200 Day Moving Average: $28.10
  • P/E Ratio: 22.13
  • P/E Growth: 1.49
  • Market Cap: $3.32B
  • Current Quarter EPS Consensus Estimate: $2.16 EPS
Additional Links:
Akorn (NASDAQ:AKRX) Chart for Sunday, June, 26, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha